|
|
Article: U.S. Food And Drug Administration Licenses INFANRIX(TM) (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed)
- Article from:
- PR Newswire
- Article date:
- January 30, 1997
CopyrightCOPYRIGHT 1997 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
-- Only acellular DTP vaccine proven more effective than whole-cell DTP --
-- To be distributed by SmithKline Beecham Pharmaceuticals --
PHILADELPHIA, Jan. 30 /PRNewswire/ -- SmithKline Beecham (SB) announced today that the U.S. Food and Drug Administration has granted a license to SmithKline Beecham Biologicals to manufacture INFANRIX(TM) (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed). INFANRIX is indicated for active immunization against diphtheria, tetanus and pertussis (whooping cough) in infants and children 6 weeks to 7 years of age (prior to seventh birthday). The vaccine will be distributed by SmithKline ...